Study to Evaluate the Effect of Sorbion Sachet S Wound Dressing

Not Applicable

Completed

• Conditions: Pressure Ulcers
• Interventions: Other: Sorbion Sachet S

• Registration Number: NCT01319097
• Lead Sponsor: Southwest Regional Wound Care Center

Brief Summary

This is a clinical study to evaluate the effects of sorbion sachet s wound dressing on soft tissue edema and wound bioburden in moderately to highly exuding pressure ulcers.

Detailed Description

This study is aimed at the participation of subject with moderately to highly exuding pressure ulcers. Each Subject is expected to participate for a period of 4 weeks or until reepithelization, which occurs first.

Study Timeline

• Study Start: 2010-04
• Study First Submitted: 2011-03-09
• Study First Submitted QC: 2011-03-17
• Study First Posted: 2011-03-21
• Primary Completion: 2011-08
• Study Completion: 2011-08
• Status Verified: 2011-09
• Last Update Submitted: 2011-09-07
• Last Update Posted: 2011-09-08

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 5

Inclusion Criteria

• Subject > 18 years.
• Subject is attending SW Wound Care Center
• Subject has a wound not smaller than 1cm2
• Subject has a wound not larger than 14cm X 23cm
• Subject has a moderately to highly exudative pressure ulcer that would be indicated for treatment with sorbion sachet S
• Subject or subject's legally authorized representative is informed about the trial, understands the nature of the study and provides written informed consent prior to study enrollment.
• Subject is willing and able to comply with all specified care and visit requirements.

Exclusion Criteria

• Subject has a lesion that does not meet the inclusion criteria.
• Subject has a pressure ulcer that contains areas of undermined tissue.
• Subject refuses to participate in the study.
• Subject is participating in another clinical study.
• Subject already participates in this study with one wound (only one wound per subject is allowed)
• Subject has known sensitivity to the trial product or any of its compounds.
• Subject is expected to be non-compliant.
• Subject uses therapy known to be immunocompromising such as systemic anti cancer drugs and/or systemic corticosteroids.
• Subject suffers from systemic infectious disease(s) known to negatively influence wound healing, such as AIDS.
• Subject's lesion is a primary skin cancer.
• Subject's lesion is the manifestation of a metastasis.
• Subject is pregnant.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Sorbion Sachet S	Sorbion Sachet S	Subject will evaluate Sorbion Sachet S dressing for 4 weeks.

Primary Outcome Measures

Name	Time	Method
The primary objective of this study is to investigate the effect of sachet S reduction on local soft tissue edema (excessive interstitial fluid to a maximum 3cm depth) in pressure ulcers.	1 year	To investigate the effect of sachet S reduction on local soft tissue edema in pressure ulcers and the degree to which sachet S influences the wound surface bioburden qualitatively and quantitatively.

Secondary Outcome Measures

Name	Time	Method
The secondary objectives are to further investigate whether sorbion sachet s	1 year	Generates changes in subjective parameters Generates changes in wound size Leads to clinician satisfaction and patient compliance with sachet s

Trial Locations

Locations (1)

Southwest Regional Wound Care Center; 🇺🇸 Lubbock, Texas, United States